Market report
Dermatological drug tenders in Czechia — market report, December 2025
Dermatological drug tenders in Czechia in December 2025: 6,652 tenders published (+6% month on month, +1% year on year), estimated at €594,111 in total, and 6,654 contracts awarded (+6% month on month, +1% year on year), worth €41,768,224 (awarded value). Buyers with the most tenders: Krajská nemocnice T. Bati, a. s. (1,698), Krajská zdravotní, a.s. (746) and Fakultní nemocnice Bulovka (581); most contracts won: ViaPharma s.r.o. (179), ROCHE s.r.o. (161) and AbbVie s.r.o. (102). On average 2.6 bids per contract; 20% of contracts had a single bid. Report made on 27 October 2026.
- Tenders published
- 6,652
- Contracts awarded
- 6,654
- Contract value awarded
- €41,768,224
- Bids per contract
- 2.6
The highlighted bar is December 2025. Hover a bar for its figure; the table below has every value.
| Figure | December 2025 | November 2025 | Change | December 2024 | Change |
|---|---|---|---|---|---|
| Tenders published | 6,652 | 6,250 | +6% | 6,565 | +1% |
| Estimated value | €594,111 | — | — | €386,903 | +54% |
| Buyers | 32 | 38 | -16% | 34 | -6% |
| Contracts awarded | 6,654 | 6,262 | +6% | 6,569 | +1% |
| Contract value (awarded) | €41,768,224 | €13,114,954 | +218% | €83,574 | +49,878% |
| Winners | 286 | 292 | -2% | 276 | +4% |
| Bids per contract | 2.6 | 1.9 | — | 1.6 | — |
| Single-bid contracts | 20% | 46% | — | 60% | — |
Buyers with the most tenders
Companies with the most contracts
| # | Winners | Contracts |
|---|---|---|
| 1 | ViaPharma s.r.o. | 179 |
| 2 | ROCHE s.r.o. | 161 |
| 3 | AbbVie s.r.o. | 102 |
| 4 | Takeda Pharmaceuticals Czech Republic s.r.o. | 97 |
| 5 | Janssen-Cilag s.r.o. | 96 |
| 6 | Gilead Sciences s.r.o. | 88 |
| 7 | Amgen s.r.o. | 83 |
| 8 | Avenier a.s. | 73 |
| 9 | Merck Sharp & Dohme s.r.o. | 65 |
| 10 | BAYER s.r.o. | 63 |
Where the tenders were
Procedures
The report's aggregates: the figures, the comparisons and the top lists by name and count.
All reports: Dermatological and musculoskeletal drugs
Questions and answers
- How many dermatological drug tenders were published in Czechia in December 2025?
- 6,652 (by 32 buyers); for comparison, November 2025: 6,250, December 2024: 6,565.
- Who won the most dermatological drug tenders in Czechia in December 2025?
- By number of contracts: ViaPharma s.r.o. (179), ROCHE s.r.o. (161), AbbVie s.r.o. (102), Takeda Pharmaceuticals Czech Republic s.r.o. (97) and Janssen-Cilag s.r.o. (96); 286 companies won contracts in all.
- Which buyers published the most dermatological drug tenders in December 2025?
- Krajská nemocnice T. Bati, a. s. (1,698), Krajská zdravotní, a.s. (746), Fakultní nemocnice Bulovka (581), Fakultní nemocnice Brno (448) and Nemocnice České Budějovice, a.s. (350).
- How competitive were dermatological drug tenders in Czechia in December 2025?
- On average 2.6 bids per contract (10 contracts with a known number of bids); 20% of contracts had a single bid.
- What were the contracts worth in December 2025?
- €41,768,224 (awarded value, 6,654 contracts); median about €3,700.
How the report is made
Tenders published: the tenders of the sector or topic whose first notice is dated in the month (a tender counts in its sector and in up to three topics). Contracts awarded: the awards dated in the month, whenever their tender was published. Values in EUR, by value kind (never added together); medians are approximate (±3 %). Comparisons: with the reports of the previous month and of the same month a year earlier, each made the same way. The report was made on 27 October 2026 from the data of that day and is not changed afterwards; sources publish late, so later data for the month are not in it.